<DOC>
	<DOCNO>NCT02113943</DOCNO>
	<brief_summary>The aim current study examine role serotonin cognitive parameter motivation . They embed conceptual framework motivation merge decision-making reinforcement learn theory . Every action conceive path one state another . The different state associate different value ( positive reward negative punishment ) , different action different cost ( risk , effort delay ) . The task design sensitivity state action parameter infer fitting computational models.The primary objective characterize effect Citalopram 30mg reward sensitivity , assess incentive force task , participant ask squeeze hand grip win monetary reward . Secondary objective characterize effect Citalopram 30mg cognitive parameter motivation ( assessed motivational battery include rating , choice learn task ) .</brief_summary>
	<brief_title>Double Blind Randomized , Monocentric , Cross-over , Placebo-controlled Study Evaluate Effect Citalopram Motivation</brief_title>
	<detailed_description />
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Man woman , age ≥ 18 &lt; 50 Weight 50 kg 90 kg . No contraindication effort No evolutive pathology could interfere current study sign consent medical insurance ( `` sécurité sociale '' ) Age &lt; 18 &gt; 50 Smokers Person curatorship , guardianship , civil right deprivation History neurologic psychiatric pathology Presence psychotropic treatment Chronic actual consumption alcohol , psychotropic drug pregnancy , breastfeed Woman childbearing potential without effective contraception Hypersensitivity atomoxetine constituent product Pheochromocytoma Narrow angle Glaucoma Liver failure Severe Cardiovascular Disorders Severe Cerebrovascular Discorders Treatment nonselective Monoamine Oxidase Inhibitor ( MAOI ) : iproniazide . Treatment Linezoline , Lithium , Milleperthuis , Tramadol , tryptans . Treatment Pimozide , treatment induce QT prolongation ( neuroleptic , class IA III antiarrythmic , moxifloxacine , erythromicine , methadone , mefloquine , tricyclic antidepressant , lithium , cisapride ) , treatment induce hydroelectrolytic inbalance ( thiazide diuretic ) . Treatment Anticoagulants Treatment decrease seizure threshold : antidepressant , neuroleptic , mefloquine , buproprione , tramadol Enzyme inducer , ( rifampicine , … ) Treatment interfere performance subject : beta2 adrenergic agonist , analgesic , corticosteroïds , antiinflammatory drug , …</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>